In summary, RBM15 promotes colon cancer development through m6A-dependent stabilization of oncogenic targets such as ITGBL1 and TMC5, while activating the JAK–STAT signaling pathway. This evidence concerns the gene SOAT1 and malignant colon neoplasm.